Oculogica

New York, United States

Oculogica specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye tracking.

$7.6M raised

May 2024

Venture - Series Unknown

Top Investors

TitletownTechGolden SeedsSofia FundColle Capital PartnersDaren Cotter

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oculogica raised?

Oculogica has raised $7.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.

Who are Oculogica's investors?

Oculogica's investors include TitletownTech, Golden Seeds, Sofia Fund, Colle Capital Partners, Daren Cotter.

Where is Oculogica headquartered?

Oculogica is headquartered in New York, United States.

What does Oculogica do?

Oculogica specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye tracking.

What stage is Oculogica at?

Oculogica is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 13, 2024.

MLA

"Oculogica — Funding & Investors." VCBacked, May 13, 2024, https://www.vcbacked.co/company/oculogica. Accessed July 1, 2026.

APA

VCBacked. (2024). Oculogica — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/oculogica

Wikipedia (cite web)

{{cite web |title=Oculogica — Funding & Investors |url=https://www.vcbacked.co/company/oculogica |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 13, 2024.